Bexmarilimab plus azacitidine shows promising response in relapsed/refractory myelodysplasia

Subcutaneous isatuximab via on-body delivery system matches IV efficacy with better experience in RRMM

Triple combination of venetoclax-ibrutinib-obinutuzumab prolongs PFS compared to venetoclax-CD20-antibodies

The combination of acimtamig and AlloNK therapy demonstrates promising efficacy in R/R cHL

POLA-R-GEMOX regimen is a promising option for relapsed/refractory diffuse large B-cell lymphoma

Ropeginterferon Alfa-2b shows superior efficacy over anagrelide in essential thrombocythaemia

Rusfertide shows promise for polycythemia vera treatment

Understanding AL amyloidosis: Treatment and diagnosis

Bloodstream buzz: Amplifying haematology through social media

Addressing challenges in palliative care

Advances in multiple myeloma treatment in the Philippines

Advances in multiple myeloma treatment